Betsy A Hirsch (Betsy Hirsch)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Single Molecule

Clinical Decision Support

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Vivek M Shastri, Lata Chauhan, Mohammed Gbadamosi, Todd A Alonzo, Yi-Cheng Wang, Richard Aplenc, Betsy A Hirsch, Edward Anders Kolb, Alan S Gamis, Soheil Meshinchi, Jatinder Kaur Lamba
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Vivek M Shastri, Lata Chauhan, Mohammed Gbadamosi, Todd A Alonzo, Yi-Cheng Wang, Richard Aplenc, Betsy A Hirsch, Edward Anders Kolb, Alan S Gamis, Soheil Meshinchi, Jatinder Kaur Lamba
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Vivek M Shastri, Lata Chauhan, Mohammed Gbadamosi, Todd A Alonzo, Yi-Cheng Wang, Richard Aplenc, Betsy A Hirsch, Edward Anders Kolb, Alan S Gamis, Soheil Meshinchi, Jatinder Kaur Lamba
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Vivek M Shastri, Lata Chauhan, Mohammed Gbadamosi, Todd A Alonzo, Yi-Cheng Wang, Richard Aplenc, Betsy A Hirsch, Edward Anders Kolb, Alan S Gamis, Soheil Meshinchi, Jatinder Kaur Lamba
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Vivek M Shastri, Lata Chauhan, Mohammed Gbadamosi, Todd A Alonzo, Yi-Cheng Wang, Richard Aplenc, Betsy A Hirsch, Edward Anders Kolb, Alan S Gamis, Soheil Meshinchi, Jatinder Kaur Lamba
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Vivek M Shastri, Lata Chauhan, Mohammed Gbadamosi, Todd A Alonzo, Yi-Cheng Wang, Richard Aplenc, Betsy A Hirsch, Edward Anders Kolb, Alan S Gamis, Soheil Meshinchi, Jatinder Kaur Lamba
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Marijana Vujkovic, Edward F Attiyeh, Rhonda E Ries, Elizabeth K Goodman, Yang Ding, Marko Kavcic, Todd A Alonzo, Yi-Cheng Wang, Robert B Gerbing, Lillian Sung, Betsy A Hirsch, Susana Raimondi, Alan S Gamis, Soheil Meshinchi, Richard Aplenc
Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report. Blood 129 (23) (2017)